Literature DB >> 22683086

Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.

Peter M Krawitz1, Yoshiko Murakami, Jochen Hecht, Ulrike Krüger, Susan E Holder, Geert R Mortier, Barbara Delle Chiaie, Elfride De Baere, Miles D Thompson, Tony Roscioli, Szymon Kielbasa, Taroh Kinoshita, Stefan Mundlos, Peter N Robinson, Denise Horn.   

Abstract

Hyperphosphatasia with mental retardation syndrome (HPMRS), an autosomal-recessive form of intellectual disability characterized by facial dysmorphism, seizures, brachytelephalangy, and persistent elevated serum alkaline phosphatase (hyperphosphatasia), was recently shown to be caused by mutations in PIGV, a member of the glycosylphosphatidylinositol (GPI)-anchor-synthesis pathway. However, not all individuals with HPMRS harbor mutations in this gene. By exome sequencing, we detected compound-heterozygous mutations in PIGO, a gene coding for a membrane protein of the same molecular pathway, in two siblings with HPMRS, and we then found by Sanger sequencing further mutations in another affected individual; these mutations cosegregated in the investigated families. The mutant transcripts are aberrantly spliced, decrease the membrane stability of the protein, or impair enzyme function such that GPI-anchor synthesis is affected and the level of GPI-anchored substrates localized at the cell surface is reduced. Our data identify PIGO as the second gene associated with HPMRS and suggest that a deficiency in GPI-anchor synthesis is the underlying molecular pathomechanism of HPMRS.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683086      PMCID: PMC3397269          DOI: 10.1016/j.ajhg.2012.05.004

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Hyperphosphatasia with mental retardation.

Authors:  K Kruse; F Hanefeld; A Kohlschütter; R Rosskamp; G Gross-Selbeck
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

3.  Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome.

Authors:  Bobby G Ng; Karl Hackmann; Melanie A Jones; Alexey M Eroshkin; Ping He; Roy Wiliams; Shruti Bhide; Vincent Cantagrel; Joseph G Gleeson; Amy S Paller; Rhonda E Schnur; Sigrid Tinschert; Janice Zunich; Madhuri R Hegde; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2012-03-22       Impact factor: 11.025

4.  Familial hyperphosphatase with mental retardation, seizures, and neurologic deficits.

Authors:  C C Mabry; A Bautista; R F Kirk; L D Dubilier; H Braunstein; J A Koepke
Journal:  J Pediatr       Date:  1970-07       Impact factor: 4.406

5.  Requirement of PIG-F and PIG-O for transferring phosphoethanolamine to the third mannose in glycosylphosphatidylinositol.

Authors:  Y Hong; Y Maeda; R Watanabe; N Inoue; K Ohishi; T Kinoshita
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

6.  Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.

Authors:  Antonio M Almeida; Yoshiko Murakami; D Mark Layton; Peter Hillmen; Gabrielle S Sellick; Yusuke Maeda; Stephen Richards; Scott Patterson; Ioannis Kotsianidis; Luigina Mollica; Dorothy H Crawford; Alastair Baker; Michael Ferguson; Irene Roberts; Richard Houlston; Taroh Kinoshita; Anastasios Karadimitris
Journal:  Nat Med       Date:  2006-06-11       Impact factor: 53.440

7.  PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol.

Authors:  Ji Young Kang; Yeongjin Hong; Hisashi Ashida; Nobue Shishioh; Yoshiko Murakami; Yasu S Morita; Yusuke Maeda; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2004-12-28       Impact factor: 5.157

8.  Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum alpha-toxin.

Authors:  Yeongjin Hong; Kazuhito Ohishi; Norimitsu Inoue; Ji Young Kang; Hiroaki Shime; Yasuhiko Horiguchi; F Gisou van der Goot; Nakaba Sugimoto; Taroh Kinoshita
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

Review 9.  Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: recent progress.

Authors:  Taroh Kinoshita; Morihisa Fujita; Yusuke Maeda
Journal:  J Biochem       Date:  2008-07-17       Impact factor: 3.387

10.  Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

Authors:  J Takeda; T Miyata; K Kawagoe; Y Iida; Y Endo; T Fujita; M Takahashi; T Kitani; T Kinoshita
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

View more
  62 in total

Review 1.  The promise of whole-exome sequencing in medical genetics.

Authors:  Bahareh Rabbani; Mustafa Tekin; Nejat Mahdieh
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

2.  Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.

Authors:  Denise Horn; Dagmar Wieczorek; Kay Metcalfe; Ivo Barić; Lidija Paležac; Mario Cuk; Danijela Petković Ramadža; Ulrike Krüger; Stephanie Demuth; Wolfram Heinritz; Tobias Linden; Jens Koenig; Peter N Robinson; Peter Krawitz
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

Review 3.  Congenital disorders of glycosylation.

Authors:  Irene J Chang; Miao He; Christina T Lam
Journal:  Ann Transl Med       Date:  2018-12

4.  Both PIGA and PIGL mutations cause GPI-a deficient isolates in the Tk6 cell line.

Authors:  Janice A Nicklas; Elizabeth W Carter; Richard J Albertini
Journal:  Environ Mol Mutagen       Date:  2015-05-13       Impact factor: 3.216

5.  Identification and In Silico Characterization of a Novel Point Mutation within the Phosphatidylinositol Glycan Anchor Biosynthesis Class G Gene in an Iranian Family with Intellectual Disability.

Authors:  Negin Parsamanesh; Hossein Safarpour; Shokoofe Etesam; Aazam Ahmadi Shadmehri; Ebrahim Miri-Moghaddam
Journal:  J Mol Neurosci       Date:  2019-08-14       Impact factor: 3.444

6.  Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.

Authors:  Xuan Yuan; Evan M Braunstein; Zhaohui Ye; Cyndi F Liu; Guibin Chen; Jizhong Zou; Linzhao Cheng; Robert A Brodsky
Journal:  Stem Cells Transl Med       Date:  2013-10-10       Impact factor: 6.940

Review 7.  Solving glycosylation disorders: fundamental approaches reveal complicated pathways.

Authors:  Hudson H Freeze; Jessica X Chong; Michael J Bamshad; Bobby G Ng
Journal:  Am J Hum Genet       Date:  2014-02-06       Impact factor: 11.025

Review 8.  Understanding human glycosylation disorders: biochemistry leads the charge.

Authors:  Hudson H Freeze
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.

Authors:  Malcolm F Howard; Yoshiko Murakami; Alistair T Pagnamenta; Cornelia Daumer-Haas; Björn Fischer; Jochen Hecht; David A Keays; Samantha J L Knight; Uwe Kölsch; Ulrike Krüger; Steffen Leiz; Yusuke Maeda; Daphne Mitchell; Stefan Mundlos; John A Phillips; Peter N Robinson; Usha Kini; Jenny C Taylor; Denise Horn; Taroh Kinoshita; Peter M Krawitz
Journal:  Am J Hum Genet       Date:  2014-01-16       Impact factor: 11.025

10.  A homozygous PIGO mutation associated with severe infantile epileptic encephalopathy and corpus callosum hypoplasia, but normal alkaline phosphatase levels.

Authors:  Yoav Zehavi; Anja von Renesse; Etty Daniel-Spiegel; Yonatan Sapir; Luci Zalman; Ilana Chervinsky; Markus Schuelke; Rachel Straussberg; Ronen Spiegel
Journal:  Metab Brain Dis       Date:  2017-09-13       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.